Central nervous system involvement in adult acute lymphocytic leukemia

被引:48
作者
Cortes, J [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
D O I
10.1016/S0889-8588(05)70203-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although involvement of the central nervous system (CNS) with acute lymphocytic leukemia is present in fewer than 10% of adults at diagnosis, without adequate prophylaxis, 30% to 50% of patients will eventually develop this complication. Effective methods of prophylaxis include intrathecal chemotherapy, high-dose systemic administration of certain agents, and cranial radiotherapy. Different approaches have been used, but it is now evident that a risk-oriented approach is effective, and there is little need for radiotherapy. Relapses in the CNS carry a poor prognosis and are frequently associated with concomitant or later systemic relapses.
引用
收藏
页码:145 / +
页数:19
相关论文
共 96 条
[1]   Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia [J].
Aricò, M ;
Valsecchi, MG ;
Camitta, B ;
Schrappe, M ;
Chessells, J ;
Baruchel, A ;
Gaynon, P ;
Silverman, L ;
Janka-Schaub, G ;
Kamps, W ;
Pui, CH ;
Masera, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) :998-1006
[2]   REMISSION INDUCTION OF MENINGEAL LEUKEMIA WITH HIGH-DOSE INTRAVENOUS METHOTREXATE [J].
BALIS, FM ;
SAVITCH, JL ;
BLEYER, WA ;
REAMAN, GH ;
POPLACK, DG .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (04) :485-489
[3]  
BALIS FM, 1989, AM J PEDIAT HEMATOL, V11, P74
[4]   DIFFERENCES IN CEREBROSPINAL-FLUID PENETRATION OF CORTICOSTEROIDS - POSSIBLE RELATIONSHIP TO THE PREVENTION OF MENINGEAL LEUKEMIA [J].
BALIS, FM ;
LESTER, CM ;
CHROUSOS, GP ;
HEIDEMAN, RL ;
POPLACK, DG .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) :202-207
[5]   CURRENT PHARMACOLOGICAL TREATMENT APPROACHES TO CENTRAL-NERVOUS-SYSTEM LEUKEMIA [J].
BLANEY, SM ;
BALIS, FM ;
POPLACK, DG .
DRUGS, 1991, 41 (05) :702-716
[6]  
Blaney SM, 1995, CANCER CHEMOTH PHARM, V36, P121
[7]  
BLEYER WA, 1988, PEDIATR CLIN N AM, V35, P789
[8]  
BLEYER WA, 1985, SEMIN ONCOL, V12, P131
[9]  
BLEYER WA, 1981, CANCER TREAT REP, V65, P89
[10]  
CASSILETH PA, 1992, LEUKEMIA, V6, P178